Daniel Wittenberg

Daniel Wittenberg

Snell & Wilmer

Contact
View Bio
RSS

Latest Posts › Biosimilars

Share:

FDA Approves Second Biosimilar – Inflectra™ – The First Monoclonal Antibody Biosimilar

The U.S. Food and Drug Administration announced on April 5 its second ever approval of a biosimilar – Inflectra (infliximab-dyyb) – for multiple indications. Inflectra was developed by Celltrion Inc. and licensed to Pfizer...more

4/8/2016  /  Affordable Care Act , Biosimilars , BPCIA , FDA Approval , Food and Drug Administration (FDA) , Patent Infringement , Pfizer , Pharmaceutical Patents
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide